Funded Tech Companies
EnClear Therapies
Headquartered in Newburyport, EnClear Therapies raised its funding from Amgen Ventures, Global Health Sciences Fund and 20/20 HealthCare Partners.
Company Overview
Company Name
EnClear Therapies
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
65 Parker St. 3A.
Newburyport, MA 01950
USA
Newburyport, MA 01950
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Company Background Information
Overview
EnClear Therapies was conceived by the founders of QurAlis and Q-State Bio, with the sole purpose of developing novel device-based therapies to treat patients with neurodegenerative disease. The companies first products will aim to halt the progression of ALS and PSP.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
2/21/2020
Financing History
Management Team
Title
Name
Email & Social
Chairman
Jonathan Fleming
Chief Executive Officer
Anthony DePasqua
Chief Medical Officer
William Gormley
Chief Scientific Officer
Kasper Roet
Co-Founder
Kevin Eggan
VP - R & D
Kevin Kalish
VP - R & D
William Siopes
Company Investors
- Amgen Ventures
- Global Health Sciences Fund
- 20/20 HealthCare Partners (Hillel Bachrach)
- Presight Capital
- Private Investors (Peter Thiel)
- Dolby Family Ventures
- Sanford Biosciences
- Thiel Capital
- Bioverge
Browse more funded tech companies:
Share this article
About Our VC & M&A Database
Our data comes from VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs